Technologies

We are a Poland-based CDMO and manufacturer of active pharmaceutical ingredients (APIs) that is proceeding with a $35 million facility expansion of its main API plant in Starogard Gdanski to include HPAPI and cryogenic technologies and investments in a pilot plant and R&D capabilities. We expect to extend our operations starting from Q1 2024, with full completion scheduled for Q3 2024.

Our capabilities:

Equipment type:

  • Various types of reactors
  • Columns
  • Crystallizers
  • Centrifuges
  • Dryers
  • Filter-dryers
  • Mills
  • Micronizers
  • Lyophilizer

Operating ranges:

  • Temp. -80°C to +200°C
  • Pressure -1 to +10 bars
  • pH in the full range

Operating ranges Pilot Plant:

  • Temp. -80°C to +200°C
  • Pressure -1 to +10 bars
  • pH in the full range

Hazardous chemistry

The use of hazardous chemistry has an aim to reduce the number of synthesis steps as well as the numberof impurities. Our key hazardous chemistry includes:

Equipment type:

  • Grignard reactions
  • Catalyzed hydrogenation
  • Metallation – Lithiation
  • Superbases handling – alkyllithium, hydrides
  • Lewis acid catalysis – boron/aluminum compounds
  • Concentrated/gaseous ammonia handling
  • Bromination/Chlorination
  • Bisphosphonation
  • Friedel-Crafts alkylation/acylation
  • Inter- and intramolecular condensations